Summary

Injectable Drug Delivery Market – Scope of Report
TMR’s report on the global injectable drug delivery market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global injectable drug delivery market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global injectable drug delivery market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the injectable drug delivery market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global injectable drug delivery market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global injectable drug delivery market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global injectable drug delivery market.

The report delves into the competitive landscape of the global injectable drug delivery market. Key players operating in the global injectable drug delivery market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global injectable drug delivery market profiled in this report.

Key Questions Answered in Global injectable drug delivery Market Report
• What is the sales/revenue generated by injectable drug delivery across all regions during the forecast period?
• What are the opportunities in the global injectable drug delivery market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Injectable Drug Delivery Market – Research Objectives and Research Approach
The comprehensive report on the global injectable drug delivery market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global injectable drug delivery market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global injectable drug delivery market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Injectable Drug Delivery Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Injectable Drug Delivery Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. PEST Analysis
5.2. Product Launches and Approvals
5.3. Regulatory Landscape for Injectable Drug Delivery in Key Regions / Countries
5.4. FDA Drug Approval Process
5.5. Key Industry Events (Acquisition, Partnerships, And Collaborations)
6. Global Injectable Drug Delivery Market Analysis and Forecasts, By Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product Type, 2020-2034
6.3.1. Devices
6.3.1.1. Conventional Injection Devices
6.3.1.2. Self Injection Devices
6.3.1.3. Others
6.3.2. Formulations
6.3.2.1. Conventional Drug Delivery Formulations
6.3.2.2. Novel Drug Delivery Formulations
6.3.2.3. Long Lasting Injection Formulations
6.4. Market Attractiveness By Product Type
7. Global Injectable Drug Delivery Market Analysis and Forecasts, By Therapeutic Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Therapeutic Application, 2020-2034
7.3.1. Autoimmune Disease
7.3.2. Hormone Disease
7.3.3. Orphan Disease
7.3.4. Cancer
7.3.5. Cardiovascular Disease
7.3.6. Infectious Disease
7.3.7. Others
7.4. Market Attractiveness By Therapeutic Application
8. Global Injectable Drug Delivery Market Analysis and Forecasts, By Usage Pattern
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Usage Pattern, 2020-2034
8.3.1. Curative Care
8.3.2. Immunization
8.3.3. Others
8.4. Market Attractiveness By Usage Pattern
9. Global Injectable Drug Delivery Market Analysis and Forecasts, By End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By End-user, 2020-2034
9.3.1. Hospitals and Clinics
9.3.2. Ambulatory Surgical Centers
9.3.3. Home Care Settings
9.3.4. Others
9.4. Market Attractiveness By End-user
10. Global Injectable Drug Delivery Market Analysis and Forecasts, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Injectable Drug Delivery Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product Type, 2020-2034
11.2.1. Devices
11.2.1.1. Conventional Injection Devices
11.2.1.2. Self Injection Devices
11.2.1.3. Others
11.2.2. Formulations
11.2.2.1. Conventional Drug Delivery Formulations
11.2.2.2. Novel Drug Delivery Formulations
11.2.2.3. Long Lasting Injection Formulations
11.3. Market Value Forecast By Therapeutic Application, 2020-2034
11.3.1. Autoimmune Disease
11.3.2. Hormone Disease
11.3.3. Orphan Disease
11.3.4. Cancer
11.3.5. Cardiovascular Disease
11.3.6. Infectious Disease
11.3.7. Others
11.4. Market Value Forecast By Usage Pattern, 2020-2034
11.4.1. Curative Care
11.4.2. Immunization
11.4.3. Others
11.5. Market Value Forecast By End-user, 2020-2034
11.5.1. Hospitals and Clinics
11.5.2. Ambulatory Surgical Centers
11.5.3. Home Care Settings
11.5.4. Others
11.6. Market Value Forecast By Country, 2020-2034
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Therapeutic Application
11.7.3. By Usage Pattern
11.7.4. By End-user
11.7.5. By Country
12. Europe Injectable Drug Delivery Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product Type, 2020-2034
12.2.1. Devices
12.2.1.1. Conventional Injection Devices
12.2.1.2. Self Injection Devices
12.2.1.3. Others
12.2.2. Formulations
12.2.2.1. Conventional Drug Delivery Formulations
12.2.2.2. Novel Drug Delivery Formulations
12.2.2.3. Long Lasting Injection Formulations
12.3. Market Value Forecast By Therapeutic Application, 2020-2034
12.3.1. Autoimmune Disease
12.3.2. Hormone Disease
12.3.3. Orphan Disease
12.3.4. Cancer
12.3.5. Cardiovascular Disease
12.3.6. Infectious Disease
12.3.7. Others
12.4. Market Value Forecast By Usage Pattern, 2020-2034
12.4.1. Curative Care
12.4.2. Immunization
12.4.3. Others
12.5. Market Value Forecast By End-user, 2020-2034
12.5.1. Hospitals and Clinics
12.5.2. Ambulatory Surgical Centers
12.5.3. Home Care Settings
12.5.4. Others
12.6. Market Value Forecast By Country, 2020-2034
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Therapeutic Application
12.7.3. By Usage Pattern
12.7.4. By End-user
12.7.5. By Country
13. Asia Pacific Injectable Drug Delivery Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product Type, 2020-2034
13.2.1. Devices
13.2.1.1. Conventional Injection Devices
13.2.1.2. Self Injection Devices
13.2.1.3. Others
13.2.2. Formulations
13.2.2.1. Conventional Drug Delivery Formulations
13.2.2.2. Novel Drug Delivery Formulations
13.2.2.3. Long Lasting Injection Formulations
13.3. Market Value Forecast By Therapeutic Application, 2020-2034
13.3.1. Autoimmune Disease
13.3.2. Hormone Disease
13.3.3. Orphan Disease
13.3.4. Cancer
13.3.5. Cardiovascular Disease
13.3.6. Infectious Disease
13.3.7. Others
13.4. Market Value Forecast By Usage Pattern, 2020-2034
13.4.1. Curative Care
13.4.2. Immunization
13.4.3. Others
13.5. Market Value Forecast By End-user, 2020-2034
13.5.1. Hospitals and Clinics
13.5.2. Ambulatory Surgical Centers
13.5.3. Home Care Settings
13.5.4. Others
13.6. Market Value Forecast By Country, 2020-2034
13.6.1. China
13.6.2. India
13.6.3. Japan
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Therapeutic Application
13.7.3. By Usage Pattern
13.7.4. By End-user
13.7.5. By Country
14. Latin America Injectable Drug Delivery Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product Type, 2020-2034
14.2.1. Devices
14.2.1.1. Conventional Injection Devices
14.2.1.2. Self Injection Devices
14.2.1.3. Others
14.2.2. Formulations
14.2.2.1. Conventional Drug Delivery Formulations
14.2.2.2. Novel Drug Delivery Formulations
14.2.2.3. Long Lasting Injection Formulations
14.3. Market Value Forecast By Therapeutic Application, 2020-2034
14.3.1. Autoimmune Disease
14.3.2. Hormone Disease
14.3.3. Orphan Disease
14.3.4. Cancer
14.3.5. Cardiovascular Disease
14.3.6. Infectious Disease
14.3.7. Others
14.4. Market Value Forecast By Usage Pattern, 2020-2034
14.4.1. Curative Care
14.4.2. Immunization
14.4.3. Others
14.5. Market Value Forecast By End-user, 2020-2034
14.5.1. Hospitals and Clinics
14.5.2. Ambulatory Surgical Centers
14.5.3. Home Care Settings
14.5.4. Others
14.6. Market Value Forecast By Country, 2020-2034
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Therapeutic Application
14.7.3. By Usage Pattern
14.7.4. By End-user
14.7.5. By Country
15. Middle East & Africa Injectable Drug Delivery Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Product Type, 2020-2034
15.2.1. Devices
15.2.1.1. Conventional Injection Devices
15.2.1.2. Self Injection Devices
15.2.1.3. Others
15.2.2. Formulations
15.2.2.1. Conventional Drug Delivery Formulations
15.2.2.2. Novel Drug Delivery Formulations
15.2.2.3. Long Lasting Injection Formulations
15.3. Market Value Forecast By Therapeutic Application, 2020-2034
15.3.1. Autoimmune Disease
15.3.2. Hormone Disease
15.3.3. Orphan Disease
15.3.4. Cancer
15.3.5. Cardiovascular Disease
15.3.6. Infectious Disease
15.3.7. Others
15.4. Market Value Forecast By Usage Pattern, 2020-2034
15.4.1. Curative Care
15.4.2. Immunization
15.4.3. Others
15.5. Market Value Forecast By End-user, 2020-2034
15.5.1. Hospitals and Clinics
15.5.2. Ambulatory Surgical Centers
15.5.3. Home Care Settings
15.5.4. Others
15.6. Market Value Forecast By Country, 2020-2034
15.6.1. GCC
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Therapeutic Application
15.7.3. By Usage Pattern
15.7.4. By End-user
15.7.5. By Country
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis By Company (2021)
16.3. Market Footprint Analysis
16.3.1. By Region
16.3.2. By Product Type
16.4. Competitive Business Strategies
16.5. Company Profiles
16.5.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.5.2. Market Share Analysis, by Company (2023)
16.5.3. Company Profiles
16.5.3.1. Becton, Dickinson, and Company (BD)
16.5.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.3.1.2. Product Portfolio
16.5.3.1.3. Financial Overview
16.5.3.1.4. SWOT Analysis
16.5.3.1.5. Strategic Overview
16.5.3.2. Pfizer, Inc.
16.5.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.3.2.2. Product Portfolio
16.5.3.2.3. Financial Overview
16.5.3.2.4. SWOT Analysis
16.5.3.2.5. Strategic Overview
16.5.3.3. Eli Lilly and Company
16.5.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.3.3.2. Product Portfolio
16.5.3.3.3. Financial Overview
16.5.3.3.4. SWOT Analysis
16.5.3.3.5. Strategic Overview
16.5.3.4. Baxter International, Inc.
16.5.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.3.4.2. Product Portfolio
16.5.3.4.3. Financial Overview
16.5.3.4.4. SWOT Analysis
16.5.3.4.5. Strategic Overview
16.5.3.5. Terumo Corporation
16.5.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.3.5.2. Product Portfolio
16.5.3.5.3. Financial Overview
16.5.3.5.4. SWOT Analysis
16.5.3.5.5. Strategic Overview
16.5.3.6. B. Braun Melsungen AG
16.5.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.3.6.2. Product Portfolio
16.5.3.6.3. Financial Overview
16.5.3.6.4. SWOT Analysis
16.5.3.6.5. Strategic Overview
16.5.3.7. Ypsomed AG
16.5.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.3.7.2. Product Portfolio
16.5.3.7.3. Financial Overview
16.5.3.7.4. SWOT Analysis
16.5.3.7.5. Strategic Overview
16.5.3.8. Gerresheimer AG
16.5.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.3.8.2. Product Portfolio
16.5.3.8.3. Financial Overview
16.5.3.8.4. SWOT Analysis
16.5.3.8.5. Strategic Overview
16.5.3.9. SCHOTT Pharma
16.5.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.3.9.2. Product Portfolio
16.5.3.9.3. Financial Overview
16.5.3.9.4. SWOT Analysis
16.5.3.9.5. Strategic Overview
16.5.3.10. Hi-Tech Syringes
16.5.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.3.10.2. Product Portfolio
16.5.3.10.3. Financial Overview
16.5.3.10.4. SWOT Analysis
16.5.3.10.5. Strategic Overview